PharmaTech

JUNE 10, 2025

It provides evidence-based recommendations on the use of vaccines for children and adults, informs decisions about insurance coverage, and helps determine eligibility for publicly funded programs such as Vaccines for Children (VFC). ACIP plays a foundational role in shaping immunization policy in the US. BIO President and CEO John F.

Vaccines 85

Vaccines Insurance Coverage and Processing Dosage Drug Development 85

Pharmaceutical Technology

JUNE 6, 2025

wants to ensure the ensuing the US does not lag behind other countries in drug development. The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing 81

Insurance Coverage and Processing Communication Hospitals Drug Development 81

Express Pharma

MARCH 16, 2025

On the global stage, AI and Machine Learning (ML) drove drug discovery and process optimisation, especially as large-scale pharma companies adopted AI for precision medicine. Building sophisticated laboratories, recruiting scientific talent, and collaborating with global research institutions are essential steps in this process.

Biosimilars 110

Biosimilars Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies 110

Pharmaceutical Technology

JUNE 23, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. In 2024, Otsuka announced the acquisition of US-based Jnana Therapeutics in a deal worth up to $1.1bn. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Hospitals 52

Pharmaceutical Technology

JULY 9, 2025

JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system. IZCARGO is the first drug developed with this technology and approved in Japan for treating a lysosomal storage disorder.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. The company is confident that these concerns, which pertain to facilities and processes rather than product quality, can be promptly addressed.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Packaging Hospitals 52

Pharmaceutical Technology

JUNE 20, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Hospitals Communication Pharmaceutical Manufacturing 52